Skip to main content
. 2019 Nov 21;12(1):30–34. doi: 10.3892/br.2019.1257

Figure 2.

Figure 2.

Investigation of the expression level of miR-192 in the tissue and serum of breast cancer patients and healthy volunteers. (A) There was a significant decrease in the level of miR-192 in cancerous tissues (***P<0.001). (B) The expression level of this miRNA remained unaltered in the serum samples. Values are presented as the means ± SD of 3 independent experiments.